These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. [Immunological and nonspecific reactivity in patients with infiltrative pulmonary tuberculosis associated with chronic nonspecific lung diseases]. Morozova TI; Khudzik LB; Rebrov AP Probl Tuberk; 1995; (4):14-7. PubMed ID: 7567859 [TBL] [Abstract][Full Text] [Related]
25. Levels of serum immunoglobulins in pulmonary tuberculosis patients. Jha VK; Bajpai BK; Gupta RM Indian J Chest Dis; 1974 Oct; 16(4):361-7. PubMed ID: 4469261 [No Abstract] [Full Text] [Related]
26. Immunological studies on Crohn's disease. III. Defective natural killer activity. Okabe N; Fujita K; Yao T J Clin Lab Immunol; 1985 Jul; 17(3):143-6. PubMed ID: 4046002 [TBL] [Abstract][Full Text] [Related]
27. [Natural cytotoxicity in systemic lupus erythematosus patients]. Aleksandrova EN; Nasonov EL; Bykhovskaia SIu; Ivanova MM; Solov'ev SK Ter Arkh; 1984; 56(5):29-32. PubMed ID: 6463883 [No Abstract] [Full Text] [Related]
28. [In vitro tuberculin reaction and cellular and humoral immune response in patients with pulmonary tuberculosis]. de Araujo AC; Takeda AK; Herrero CB; de Freitas IW; Nakandakare IK; Guedes EA; Brólio R Rev Saude Publica; 1983 Apr; 17(2):94-111. PubMed ID: 6648301 [No Abstract] [Full Text] [Related]
29. [Natural killer cells in middle-aged and elderly tuberculosis patients]. Adambekov DA Zh Mikrobiol Epidemiol Immunobiol; 1995; (1):18-21. PubMed ID: 7778367 [TBL] [Abstract][Full Text] [Related]
30. Open versus laparoscopic surgery: a comparison of natural antitumoral cellular immunity in a small animal model. Sandoval BA; Robinson AV; Sulaiman TT; Shenk RR; Stellato TA Am Surg; 1996 Aug; 62(8):625-30; discussion 630-1. PubMed ID: 8712558 [TBL] [Abstract][Full Text] [Related]
34. [Comprehensive study of patient immunological reactivity in combined pulmonary tuberculosis and diabetes mellitus]. Adambekov DA; Al'dzhambaev ShIu; Pokotilo DI Probl Tuberk; 1980 Jun; (6):25-7. PubMed ID: 7393905 [No Abstract] [Full Text] [Related]
35. [THE USE OF "REAMBERIN" AS BIOLOGICAL RESPONSE MODIFIER TO INCREASE THE NATURAL KILLER CELLS' CYTOTOXICITY IN PATIENTS WITH LUNG TUBERCULOSIS]. Kholamov AI; Mirzomogomedova VG; Chernoshey DA; Lizunov ES Eksp Klin Farmakol; 2015; 78(8):22-4. PubMed ID: 26591578 [TBL] [Abstract][Full Text] [Related]
37. [Significance of biochemical and immunological indices in the diagnosis of the activity of limited forms of pulmonary tuberculosis]. Kostina ZI; Pokhodzeĭ IV; Kotenko TV; Gerasimova EV; Obrosova TI Probl Tuberk; 1986; (4):18-23. PubMed ID: 3714697 [No Abstract] [Full Text] [Related]
38. [Tuberculosis in the course of Hodgkin's disease]. Leménager J; Tanguy A; Bérnard Y Cah Med; 1972 Apr; 13(5):357-62. PubMed ID: 5055112 [No Abstract] [Full Text] [Related]
39. Influence of HLA-DR2 on perforin-positive cells in pulmonary tuberculosis. Rajeswari DN; Selvaraj P; Raghavan S; Jawahar MS; Narayanan PR Int J Immunogenet; 2007 Oct; 34(5):379-84. PubMed ID: 17845310 [TBL] [Abstract][Full Text] [Related]
40. [Immunological studies of pulmonary infection with atypical mycobacteria I. Enumeration of lymphocyte subsets in the peripheral blood]. Harada Y; Harada S; Takamoto M; Kitahara Y; Ishibashi T; Shinoda A Kekkaku; 1988 Aug; 63(8):555-61. PubMed ID: 3184586 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]